EU Agency Backs Novartis’ Votubia for Kidney Tumors

European regulators on Friday recommended approval of a Novartis’ drug Votubia for the treatment of non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex.
Reuters